CorMedixvsEli Lilly and Company

CRMD and LLY stock compared: price, dividend, valuation and results, from SEC filings.

LLY

Eli Lilly and Company

$1,382.75

Value $1.30T

-2.32%
LLY's page

CorMedix (CRMD) has a market value of $356M and Eli Lilly and Company (LLY) $1.30T. Over the last year, with dividends, CRMD moved -54.9% and LLY +36.2%. The P/E is 5.6 for CRMD and 47.3 for LLY. Dividend yield: CRMD none, LLY 0.46%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CRMD$356M

    LLY$1.30T

    LLY is 3,667 times CRMD

  • Revenue, 12 months

    CRMD$412M

    LLY$86.5B

    LLY is 210 times CRMD

  • Net income, 12 months

    CRMD$64M

    LLY$27.6B

    LLY is 432 times CRMD

  • Operating margin

    CRMD38.6%

    LLY–

  • ROIC

    CRMD27.3%

    LLY35.5%

    8.2 points apart

  • P/E

    CRMD5.6

    LLY47.3

    LLY is 8.5 times CRMD

  • Dividend yield

    CRMD0.0%

    LLY0.5%

    0.5 points apart

  • 5-year return

    CRMD-11.2%

    LLY+452.8%

    464.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CRMD-11.3%

LLY+452.8%

20040060020222023202420252026
Returns by period
PeriodCRMDWith dividendsLLYWith dividends
1 year since November 17, 2025-54.9%Price -54.9%+36.2%Price +35.3%
3 years since November 17, 2023+12.2%+3.9% a yearPrice +12.2%+138.4%+33.6% a yearPrice +133.7%
5 years since November 17, 2021-11.2%-2.4% a yearPrice -11.2%+452.8%+40.8% a yearPrice +429.4%
10 years since November 18, 2016-51.1%-6.9% a yearPrice -51.1%+1,997.9%+35.6% a yearPrice +1,703.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CRMDCorMedixLLYEli Lilly and Company

Valuation

CRMDLLY
Valuation
Price$4.50$1,382.75
Market value$356M$1.30T
Enterprise value (EV)$721.4K$1.35T
P/E5.647.3
P/E, 5-year median–49.9
P/B0.832.4
EV/EBIT–38.8
Free cash flow yield86.5%1.5%

Results and growth

CRMDLLY
Results and growth
Revenue, 12 months$412M$86.5B
Net income, 12 months$64M$27.6B
Free cash flow, 12 months$308M$19.7B
Earnings per share, 12 months$0.81$30.81
Revenue growth, year on year617.0%44.7%
Revenue growth a year, past+319.8%over 5 years+21.6%over 5 years
EPS growth a year, past–+27.6%over 5 years

Margins and returns on capital

CRMDLLY
Margins and returns on capital
Gross margin77.5%83.6%
Operating margin38.6%–
Net margin15.5%31.9%
ROIC27.3%35.5%
ROE14.9%88.6%

Balance sheet

CRMDLLY
Balance sheet
Cash$355M$4.9B
Total debt$144.6K$49.5B
Net debt / EBITDA-2.21.2
Interest cover57.2×38.9×

Dividends and buybacks

CRMDLLY
Dividends and buybacks
Dividend yield–0.5%
Dividend per share, 12 months–$6.34
Dividend growth a year, past–+15.2%over 5 years
Buyback yield–0.3%
Shareholder yield–0.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CRMD or LLY

Didn't find what you were looking for?

Ask us
Which is bigger, CorMedix or Eli Lilly and Company?

By market value, Eli Lilly and Company ($1.30T) is about 3,666.9 times CorMedix ($356M), at today's prices.

How did CRMD and LLY stock do over the last 10 years?

Since November 18, 2016, CRMD's price moved -51.1% and LLY's +1,703.5%. With dividends: CRMD -51.1% (-6.9% a year), LLY +1,997.9% (+35.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, CRMD or LLY?

The dividend yield at today's price is none for CorMedix and 0.46% for Eli Lilly and Company. Over the last twelve months they paid – and $6.34 per share.

What is the P/E of CRMD and LLY?

At today's price, the P/E is 5.6 for CRMD and 47.3 for LLY. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, CorMedix or Eli Lilly and Company?

Over the last twelve months, the net margin was 15.5% for CorMedix and 31.9% for Eli Lilly and Company, and the operating margin 38.6% and –. Revenue was $412M and $86.5B.

Which is the better investment, CorMedix or Eli Lilly and Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.